Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Biotricity's operating income for the twelve months ending Jun 30, 2026 was $1.57M. For fiscal 2026 it was $1.69M. The highest annual figure on record is $1.69M in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.69M | – |
| FY2025 | Mar 31, 2025 | -$2.45M | – |
| FY2024 | Mar 31, 2024 | -$8.83M | – |
| FY2023 | Mar 31, 2023 | -$15.41M | – |
| FY2022 | Mar 31, 2022 | -$16.74M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $158.07K | -43.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $694.56K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $440.92K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $273.82K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $281.95K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$855.47K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$168.98K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$307.67K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.12M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$3.04M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$1.28M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.19M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.32M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$3.45M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$3.84M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$3.83M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$4.74M | – |
See a number that looks wrong?